Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

May 28, 2015

Hackett lauded as one of Women to Watch in health care

Lauren Hackett, MPA, executive director of Administration at Vanderbilt-Ingram Cancer Center (VICC) and chief business officer for Oncology, Imaging and Quantitative Sciences Administration, has been chosen as one of the 2015 Women to Watch by Nashville Medical News.

By VUMC News and Communications
May 21, 2015

VICC Annual Retreat focuses on immunotherapy

Efforts to enable the immune system to “see” the cancer and attack the aberrant cells were the prime focus during Vanderbilt-Ingram Cancer Center’s Annual Retreat, held April 30 at the Vanderbilt University Student Life Center.

By VUMC News and Communications
May 14, 2015

Jansen’s cancer research efforts garner recognition

Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research.

By VUMC News and Communications
May 5, 2015

Kachnic to join VUMC as new chair of Radiation Oncology

Lisa Kachnic, M.D., professor and chair of Radiation Oncology and associate director of Multidisciplinary Cancer Research at Boston University School of Medicine (BUSM), and chief of Radiation Oncology at Boston Medical Center (BMC), has been named the new professor and chair of the Vanderbilt Department of Radiation Oncology. She will join the faculty on Sept. 21.

By John Howser
April 30, 2015

VICC cancer research efforts in spotlight at AACR conference

Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer.

By VUMC News and Communications
April 30, 2015

VICC at Franklin adds new radiation therapy technology

The Vanderbilt-Ingram Cancer Center (VICC) at Franklin has added new technology to enhance treatment for patients needing radiation therapy or stereotactic body radiation.

By VUMC News and Communications
April 9, 2015

Free screening event for head and neck cancer set for April 17

Of every 100 people in the United States, at least three men or women will be diagnosed with head and neck cancer in their lifetimes. These cancers can occur in the nasal cavity, sinuses, throat, lips, mouth, thyroid, salivary glands or the voice box (larynx).
By VUMC News and Communications
April 2, 2015

Study explores driver behind lung cancer tumor progression

Vanderbilt-Ingram Cancer Center investigators have identified the mechanisms used by a gene and its binding protein to drive tumor growth in several forms of cancer, including non-small cell lung cancer.
By VUMC News and Communications
March 19, 2015

VICC’s Johnson to study cancer survivorship with immune inhibitor drugs

By VUMC News and Communications
March 12, 2015

VICC set to host preview of PBS cancer documentary

Vanderbilt-Ingram Cancer Center, along with Nashville Public Television (NPT), the American Cancer Society and Gilda’s Club Nashville, will sponsor a special community event to preview an upcoming PBS television documentary on cancer.
By VUMC News and Communications
March 12, 2015

Gene mutations may predict melanoma response to immunotherapies

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators.
By VUMC News and Communications
March 5, 2015

Moses, Shyr named to Institute of Medicine cancer therapies panel

Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies.
By VUMC News and Communications
February 26, 2015

Cancer survival improvements vary by age, race

Improvements in cancer diagnosis and treatment have led to longer survival for most cancer patients in the United States. However, the improvement in survival was substantially greater among younger patients and those who are white in most of the cancers studied, according to new research by Vanderbilt University investigators.
By VUMC News and Communications